| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |